Background Accumulating evidence suggests a beneficial effective of tumour necrosis factor‐
alpha (TNF‐α) inhibitors on the outcomes of COVID‐19 disease, which, however is not …

Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the
impact of the COVID-19 pandemic on disease management. We conducted this overview by …

Objective With a vaccine effectiveness of 95% for preventing coronavirus disease 2019
(COVID‐19), Pfizer‐BioNTech BNT162b2 (BNT162b2) was the first vaccine against severe …

В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …

The impact of SARS-CoV-2 infection in patients with autoimmune/auto-inflammatory
rheumatic diseases (AARD) under immunomodulatory treatment has been a focus of interest …

Abstract Background Coronavirus disease 2019 (COVID-19) induces inflammation,
autoantibody production, and thrombosis, which are common symptoms of autoimmune …

The objectives of the study were to review the articles to identify (a) the epidemiology of
systemic lupus erythematosus (SLE) and coronavirus disease 2019 (COVID-19);(b) the …

Objectives To investigate coronavirus disease 2019 (COVID-19)-associated risk of
hospitalization and death in RA, AS, PsA, SLE and SSc in comparison with the general …

Abstract Purpose of Review To describe the current state of knowledge regarding COVID-19
in patients with systemic lupus erythematosus (SLE). We focus on (i) SARS-CoV-2 …

Background: Seroconversion and longevity of vaccine-induced immune response is blunted
in immune-mediated inflammatory disease (IMID) patients owing to immunosuppressive …